Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Carmelo Capula"'
Autor:
Daniela Foti, Luigi Puccio, Carmelo Capula, Massimo Borelli, Anna Vero, Eusebio Chiefari, Antonio Brunetti, Rosa Oliverio, Raffaella Vero
Publikováno v:
Primary Care Diabetes. 10:315-323
The Italian National Institute of Health has recently introduced a selective screening based on the risk profile of pregnant women, which while recommending against screening of women at low risk (LR) for GDM, it recommends an early test for women at
Autor:
Vincenzo Scorcia, Eusebio Chiefari, Daniela Foti, Monica Fedele, Valeria Ventura, Antonio Brunetti, Alfredo Fusco, Biagio Arcidiacono, Carmelo Capula, Camillo Palmieri, Maria T. Nevolo, Giorgio Randazzo, Francesco Luciano Bilotta, Raffaella Vero, Michela Vitiello, Elio Gulletta
Publikováno v:
Scientific reports (Nature Publishing Group) 6 (2016). doi:10.1038/srep39429
info:cnr-pdr/source/autori:Chiefari E.; Ventura V.; Capula C.; Randazzo G.; Scorcia V.; Fedele M.; Arcidiacono B.; Nevolo M.T.; Bilotta F.L.; Vitiello M.; Palmieri C.; Gulletta E.; Fusco A.; Foti D.; Vero R.; Brunetti A./titolo:A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression/doi:10.1038%2Fsrep39429/rivista:Scientific reports (Nature Publishing Group)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume:6
Scientific Reports
info:cnr-pdr/source/autori:Chiefari E.; Ventura V.; Capula C.; Randazzo G.; Scorcia V.; Fedele M.; Arcidiacono B.; Nevolo M.T.; Bilotta F.L.; Vitiello M.; Palmieri C.; Gulletta E.; Fusco A.; Foti D.; Vero R.; Brunetti A./titolo:A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression/doi:10.1038%2Fsrep39429/rivista:Scientific reports (Nature Publishing Group)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume:6
Scientific Reports
Diabetic retinopathy (DR) is a major complication of diabetes mellitus, and is the leading cause of blindness in working-age people. Usually, DR progresses from the asymptomatic non-proliferative DR that does not significantly alter vision, to prolif
Autor:
Daniela Foti, Eusebio Chiefari, Luigi Puccio, Ada Vero, Raffaella Vero, Manfredi Greco, Antonio Brunetti, Vittorio Pullano, Carmelo Capula, Rosa Oliverio, Rossella Liguori, Domenico Tirinato
Publikováno v:
Diabetes technologytherapeutics. 17(7)
Liraglutide is a glucagon-like peptide-1 receptor analog recently approved for the treatment of type 2 diabetes mellitus (T2DM). We aimed to assess the efficacy and safety of liraglutide versus glimepiride, as adjunct treatments to metformin, in achi
Publikováno v:
Diabetes research and clinical practice. 105(2)
Aims To determine the prevalence of both prediabetes and type 2 diabetes mellitus (T2DM) by postpartum oral glucose tolerance test (ppOGTT) in Italian women diagnosed with gestational diabetes mellitus (GDM), and identify antepartum predictors of glu
Autor:
Carmelo Capula, Stefania Iiritano, Luigi Puccio, Biagio Arcidiacono, Daniela Foti, Raffaella Vero, Vittorio Pullano, Antonio Brunetti, Anna Vero, Eusebio Chiefari
Publikováno v:
ISRN Endocrinology
Postpartum screening is critical for early identification of type 2 diabetes in women previously diagnosed with gestational diabetes mellitus (GDM). Nevertheless, its rate remains disappointingly low. Thus, we plan to examine the rate of postpartum g
Autor:
Marcello Orio, Raffaella Vero, Fulvio Zullo, Francesco Orio, Achille Tolino, Angela Falbo, Tiziana Russo, Stefano Palomba, Annamaria Colao, Andrea Gregorio Cosco, Carmelo Capula, Laura Rivoli
Publikováno v:
Diabetes Care
OBJECTIVE To test the hypothesis that the risk of persistent glucose impairment after gestational diabetes mellitus (GDM) is increased in patients with polycystic ovary syndrome (PCOS). RESEARCH DESIGN AND METHODS The prospective case-control study i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be217ccbf74146f356f73f16a7f8cc3a
https://hdl.handle.net/11573/1663617
https://hdl.handle.net/11573/1663617
Autor:
Eusebio, Chiefari, Sinan, Tanyolaç, Francesco, Paonessa, Clive R, Pullinger, Carmelo, Capula, Stefania, Iiritano, Tommaso, Mazza, Michele, Forlin, Alfredo, Fusco, Vincent, Durlach, Anne, Durlach, Mary J, Malloy, John P, Kane, Steven W, Heiner, Mirella, Filocamo, Daniela P, Foti, Ira D, Goldfine, Antonio, Brunetti
Publikováno v:
JAMA. 305(9)
High-mobility group A1 (HMGA1) protein is a key regulator of insulin receptor (INSR) gene expression. We previously identified a functional HMGA1 gene variant in 2 insulin-resistant patients with decreased INSR expression and type 2 diabetes mellitus
Autor:
Antonio Brunetti, Stefania Iiritano, Francesco Paonessa, Daniela Foti, Eusebio Chiefari, Carmelo Capula, Katiuscia Possidente, Aurora Nocera, Biagio Arcidiacono
Publikováno v:
BMC Geriatrics, Vol 10, Iss Suppl 1, p A91 (2010)
Europe PubMed Central
BMC Geriatrics
Europe PubMed Central
BMC Geriatrics
Background Type 2 diabetes mellitus is a very common metabolic disorder affecting ~200 million people worldwide [1]. Chronic complications of the disease due to poor metabolic control are specifically associated with long-term damage, dysfunction and
Autor:
John P. Kane, Anne Durlach, Antonio Brunetti, Daniela Foti, Mary J. Malloy, Steven W. Heiner, Francesco Paonessa, Ira D. Goldfine, Alfredo Fusco, Carmelo Capula, Michele Forlin, Tommaso Mazza, V. Durlach, Clive R. Pullinger, Eusebio Chiefari, Mirella Filocamo, Sinan Tanyolaç, Stefania Iiritano
Publikováno v:
JAMA. 305:903
Context High-mobility group A1 (HMGA1) protein is a key regulator of insulin receptor (INSR) gene expression. We previously identified a functional HMGA1 gene variant in 2 insulin-resistant patients with decreased INSR expression and type 2 diabetes
Autor:
Rocco Bruno, Paolo Giannasio, Rosarita Chiarella, Carmelo Capula, Diego Russo, Sebastiano Filetti, Giuseppe Costante
Publikováno v:
Thyroid; May2009, Vol. 19 Issue 5, p531-533, 3p